Related Experiment Videos
Severe sorafenib-induced hand-foot skin reaction
Abstract:
Sorafenib is a new drug, multikinase inhibitor, which has been recently approved for the treatment of metastatic renal cell carcinoma and hepatocellular carcinoma. Up to 90 percent of patients receiving this drug have been reported to develop dermatological symptoms. Recently, it has been suggested that the appearance of skin toxicity during therapy may indicate antitumor activity. We report a new case of sorafenib-induced severe hand-foot skin reaction, which hindered the patient's normal life. The reaction was successfully treated with topical costicosteroids and discontinuation of sorafenib. However, the patient died one month later.
Insights
Sorafenib can cause severe skin reactions in cancer patients. While topical treatments may help, this case highlights the drug
Area of Science:
- Oncology
- Dermatology
Background:
- Sorafenib, a multikinase inhibitor, is approved for metastatic renal cell carcinoma and hepatocellular carcinoma.
- Dermatological side effects, including hand-foot skin reaction (HFSR), affect up to 90% of patients on sorafenib.
- Emerging evidence suggests a correlation between skin toxicity and sorafenib's antitumor activity.
Observation:
- A case of severe sorafenib-induced hand-foot skin reaction is presented.
- The reaction significantly impaired the patient's daily activities.
- Treatment involved topical corticosteroids and sorafenib discontinuation.
Findings:
- Successful management of severe hand-foot skin reaction with topical corticosteroids and drug cessation.
- Despite treatment, the patient experienced a fatal outcome one month post-intervention.
Implications:
- Severe skin toxicity from sorafenib can be managed symptomatically.
- The correlation between sorafenib's skin toxicity and therapeutic efficacy requires further investigation.
- Patient outcomes underscore the critical need for vigilant monitoring and management of adverse events in targeted cancer therapy.
Related Concept Videos
Drug Toxicity: Allergic Reactions
Drug toxicity: Idiosyncratic Reactions
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome III : Nursing Management
Nephrotic Syndrome II : Assessment and Medical Management
Diabetic Foot Ulcer